PulmoFast

Nodule detection

PulmoFast is our proprietary application for automated detection of pulmonary nodules by using AI.

Preliminary studies have shown results exceeding expectation.

PulmoFast is currently undergoing clinical validation and regulatory approval.

Pulmonary Nodules

A pulmonary nodule is a small round or oval-shaped growth in the lung. It may also be called a “spot on the lung” or a “coin lesion.” Pulmonary nodules are smaller than three centimeters (around 1.2 inches) in diameter. If the growth is larger than that, it is called a pulmonary mass and is more likely to represent a cancer than a nodule.

Countless pulmonary nodules are discovered each year during chest X-rays or CT scans. Most nodules are noncancerous (benign). A solitary pulmonary nodule is found on up to 0.2% of all chest X-rays films. Lung nodules can be found on up to half of all lung CT scans. Risk factors for malignant pulmonary nodules include a history of smoking and older age.

Further reading

Distribution

PulmoFast is exclusively distributed via the Holland AI platform, the global integrated connectivity solution linking cloud-based AI and machine learning applications with legacy hospital infrastructure.

This minimizes operational impact for implementation, whilst maximizing output and enabling deployment of a wide plethora of AI applications to your hospital.

Holland AI Platform for AI distribution

Features

Designed and built based on requirements from radiologists, user-centric, fully integrated into the existing workflow.

Reach out to discuss your requirements Schedule a Demonstration Case Study – Clinical Validation PulmoFast

Pricing

After obtaining regulatory approval, PulmoFast will be made available at a competitive transaction-based pricing model, creating greater value whilst simultaneously reducing costs, creating a leap in value for doctors, hospitals and society.

This stems from our belief AI should add value at reasonable costs, with transparent pricing, improving diagnostics.